stat.MLNov 7, 2026

Beyond Discrete Ancestry Groups: Distribution-Aware In-Context Learning for Cancer Outcome Prediction Across the Genetic Ancestry Continuum

Authors: Weizhi Li, Yan Cui

Organizations: Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA

Abstract

Machine learning models for omics-based prediction of cancer outcomes are commonly built on aggregated data without distinguishing ancestry groups, or under an ancestry-discrete design, which partitions samples into ancestry groups and fits a separate model within each group. Recent evidence shows that this approach is inherently limited: predictive accuracy declines with genetic distance from the training samples, even within a single ancestry group, because the data distribution shifts continuously rather than only between predefined categories. In this paper, we propose distribution-aware in-context learning (DA-ICL) for ancestry-continuum modeling. Our method extends conventional ancestry-discrete modeling to ancestry-continuum modeling, capturing the nonstationary omics-endpoint relationship across the genetic continuum while enabling efficient modeling through an in-context learning foundation model. We provide theoretical analysis demonstrating the superiority of the ancestry-continuum over ancestry-discrete modeling, along with empirical results supporting the proposed framework. Source code is available at https://github.com/ai4pm/DA-ICL-Continuum.

Figures & tables

Explore similar work

Oct 6, 2026

GeneICL: A Tabular Foundation Model for Bulk Transcriptomics

Gene expression is widely measured in biomedicine, yet clinical outcome prediction remains challenging due to high dimensionality, strong feature correlations, and limited labeled data. Large self-supervised transcriptomic foundation models often fail to outperform simple supervised baselines. Tabular foundation models offer an alternative through in-context learning, but are typically pretrained on generic synthetic data rather than transcriptomic structure. We ask whether transcriptomics-aware pretraining, rather than scale, is the missing ingredient. Towards this end, we introduce GeneICL, a 4.2M-parameter tabular foundation model combining a semi-synthetic pretraining prior built from measured bulk expression profiles with a parameter-efficient recurrent architecture. We further enable right-censored survival prediction via a training-free reduction to regression using Cox partial-likelihood residuals. We evaluate GeneICL on 80 clinical outcome-prediction tasks spanning classification, regression, and survival. Tabular foundation models consistently outperform self-supervised transcriptomic models, while GeneICL achieves the best overall rank among evaluated foundation models and tuned baselines. GeneICL does so with up to 387×\times fewer parameters, no gradient updates at inference, and predictions within seconds on a laptop CPU.
Jul 4, 2026

SHIFT: Survival Prediction from Incomplete and Heterogeneous Genomic Data

Genomic prediction models often fail to transfer across institutions because sequencing panels differ across sites, creating structural feature missingness at deployment. Existing approaches to this challenge typically restrict analysis to genes shared across cohorts, exclude patients with incomplete profiles, or rely on test-time imputation, all of which can reduce robustness and limit the use of multi-center data. We propose Survival prediction Handling Incomplete Features using Transformer (SHIFT), a missingness-aware survival model that directly predicts from incomplete genomic inputs without test-time imputation. SHIFT represents each genomic feature separately and uses masked self-attention, along with a feature-availability mask, so that predictions are based only on observed inputs. Further, we introduce variable-rate feature masking during training to improve robustness to heterogeneous missingness patterns. We evaluate the approach on glioblastoma and lung squamous cell carcinoma with external validation across multiple cohorts, including a challenging setting with severe cross-cohort panel mismatch. Across these settings, SHIFT shows strong generalization and compares favorably with standard survival baselines and imputation-based approaches, while using a single model across differing feature sets. We also find that incorporating patients from incomplete cohorts during development can improve performance on external data, suggesting that partially observed cohorts need not be excluded from model building. These results support missingness-aware modeling as a practical strategy for multi-center survival prediction in precision oncology.
Apr 27, 2026

CMGL: Confidence-guided Multi-omics Graph Learning for Cancer Subtype Classification

Motivation: Multi-omics integration can improve cancer subtyping, but modality informativeness and noise vary across cancer types and patients. Most graph methods for multi-omics data learn modality contributions within the downstream classification objective, leaving predictive reliability for each patient implicit. As a result, uninformative modalities can weaken the fused representation, while unreliable omics can introduce noisy patient relationships into graph propagation. To address these two problems, we propose CMGL, which produces a separate reliability estimate before fusion and uses consensus patient neighborhoods for graph classification. Results: CMGL estimates modality confidence for each patient through evidential deep learning, fixes these values during fusion across omics, and performs classification on an independently specified consistency graph. On four MLOmics cancer-subtype tasks and the 32-class pan-cancer task, CMGL consistently improves over the strongest baseline, surpassing it by 4.03% in average accuracy on the four single-cancer tasks. Its representations recover the PAM50 intrinsic subtypes of breast invasive carcinoma (BRCA), and the model trained on BRCA transfers without fine tuning to kidney renal clear cell carcinoma (KIRC), stratifying patients into prognostically distinct groups.